Identification of μ-crystallin as an androgen-regulated gene in human prostate cancer

Prostate

Volumn 69, Issue 10, 2009, Pages 1109-1118

  Malinowska, Kamilla ^a   Cavarretta, Ilaria T ^a   Susani, Martin ^b   Wrulich, Oliver A ^a   Kenner, Lukas ^b,c   Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

crystallin; Androgen receptor; Prostate cancer

Indexed keywords

ALPHA AMANITIN; ANDROGEN RECEPTOR; LIOTHYRONINE; MESSENGER RNA; METRIBOLONE; SMALL INTERFERING RNA; THYMIDINE; ANDROGEN; CARRIER PROTEIN; CRYSTALLIN; CRYSTALLIN MU; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE BINDING PROTEINS; THYROID HORMONE-BINDING PROTEINS; TUMOR MARKER; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION; HORMONAL THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MU CRYSTALLIN GENE; PRIORITY JOURNAL; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; MALE; ORCHIECTOMY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; UPREGULATION;

ANDROGENS; CARRIER PROTEINS; CELL LINE, TUMOR; CRYSTALLINS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; ORCHIECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, MESSENGER; THYROID HORMONES; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 67449126784     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20956     Document Type: Article

References (28)

1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Huggins C, Hodges C. Studies on prostate cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate. Cancer Res 1941;1:239-297.
4. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J. Androgen receptors in endocrine-therapy- resistant human prostate cancer. Int J Cancer 1991;48:189-193.
5. Porkka KP, Visakorpi T. Molecular mechanisms of prostate cancer. Eur Urol 2004;45:683-691.
6. Culig Z, Steiner H, Bartsch G, Hobisch A. Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours. Endocr Relat Cancer 2005;12:229-244. (Pubitemid 40896443)
7. Segovia L, Horwitz J, Gasser R, Wistow G. Two roles for μ-crystallin: A lens structural protein in diurnal marsupials and a possible enzyme in mammalian retinas. Mol Vision 1997;3:9.
8. Umeda S, Suzuki MT, Okamoto H, Ono F, Mizota A, Terao K, Yoshikawa Y, Tanaka Y, Iwata T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J 2005;19:1683-1685. (Pubitemid 41429529)
9. Roberts MR, Srinivas M, Forrest D, Morreale de Escobar G, Reh TA. Making the gradient: Thyroid hormone regulates cone opsin expression in the developing mouse retina. Proc Natl Acad USA 2006;103:6218-6223.
10. Primm TP, Gilbert HF. Hormone binding by protein disulfide isomerase, a high capacityhormonereservoir of the endoplasmic reticulum. J Biol Chem 2001;276:281-286. (Pubitemid 32050318)
11. Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner R, Cabello G, Wrutniak C. A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 1999;19:7913-7924. (Pubitemid 30413986)
12. Mori J, Suzuki S, KobayashiM, Inagaki T, Komatsu A, Takeda Miyamoto T, Ichikawa K, Hashizume K. Nicotinamide adenine dinucleotide phosphate-dependent cytosolic T(3) binding protein as a regulator for T(3)-mediated transactivation. Endocrinology 2002;143:1538-1544.
13. Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, Hashizume micro-Crystallin as an intracellular 3,5,30-triiodothyronine holder in vivo. Mol Endocrinol 2007;21:885-894.
14. Haag P, Bektic J, Bartsch G, Klocker H, Eder IE. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 2005;96:251-258. (Pubitemid 41080506)
15. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976;72:248-254.
16. Mousses S, Bubendorf L, Wagner U, Hostetter G, Kononen Cornelison R, Goldberger N, Elkahloun AG, Willi N, Koivisto Fehrle W, Raffeld M, Sauter G, Kallioniemi OP. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue micro-arrays. Cancer Res 2002;62:1256-1260. (Pubitemid 34407773)
17. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, pathak S, von Eschenbach AC, Logothetis CJ. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Clin Cancer Res 1997; 3:2493-2500.
18. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White Hood L, Lin B. The program of androgen-responsive genes neoplastic prostate epithelium. Proc Natl Acad Sci USA 2002; 11890-11895. (Pubitemid 34994494)
19. Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs Krause M, Hanash S, Chen YQ. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 2001;1:1327-1338. (Pubitemid 33587888)
20. Veldscholte J, Voorhorst-Ogink MM, Bolt-de Vries J, van Rooij HC, Trapman J, Mulder E. Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: High affinity for progestagenic and estrogenic steroids. Biochim Biophys Acta 1990;1052:187-194. (Pubitemid 20113181)
21. Zhao XY, Boyle B, Krishnan AV, Navone NM, Peehl DM, Feldman D. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. J Urol 1999;162:2192-2199.
22. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997; 402-408. (Pubitemid 27145681)
23. Moehren U, Papaioannou M, Reeb CA, Grasselli A, Nanni S, Asim M, Roell D, Prade I, Farsetti A, Baniahmad A. Wild-type but not mutant androgen receptor inhibits expression of the hTERT telomerase subunit: A novel role of AR mutation for prostate cancer development. FASEB J 2008;22:1258-1267.
24. Zhang S, Hsieh ML, Zhu W, Klee GG, Tindall DJ, Young CY. Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression. Endocrinology 1999;140:1665-1671. (Pubitemid 29149235)
25. Aoki N, Ito K, Ito M. mu-Crystallin, thyroid hormone-binding protein, is expressed abundantly in the murine inner root sheath cells. J Invest Dermatol 2000;115:402-405. (Pubitemid 30695762)
26. Hashizume K, Suzuki S, Ichikawa K, Takeda T, Kobayashi M. Effect of active vitamin D3 on the levels of NADPH-dependent cytosolic 3,5,30-triiodo-L-thyronine-binding protein. Biochem Biophys Res Commun 1991;177:388-394.
27. Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR, Huang JY, Chou SH, Tsai MS, Hwang JJ, Lin SR. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. Oncol Rep 2006;16:981-988.
28. Khalil AA. Biomarker discovery: A proteomic approach for brain cancer profiling. Cancer Sci 2007;98:201-213. (Pubitemid 44941872)